Investors Land ITCI Even Cheaper Than Its Secondary Stock Offering
January 10, 2022 at 10:12 AM EST
Looking back to 6 days ago, Intra-Cellular Therapies Inc (ITCI) priced a 9,523,810 share secondary stock offering at $42.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..